Lista de obras - Antonio C. Wolff - Dominio Público Uruguay

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline

artículo científico publicado en 2006

A PIK3CA mutation detected in plasma from a patient with synchronous primary breast and lung cancers.

artículo científico publicado en 2013

A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB)

scientific article published on 05 February 2019

A Validated Model for Identifying Patients Unlikely to Benefit From the 21-Gene Recurrence Score Assay.

artículo científico publicado en 2015

A method for determination of dimethyl benzoylphenyl urea (BPU) in human plasma by using LC/UV.

artículo científico publicado en 2004

A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin

artículo científico publicado en 2004

A randomized phase II feasibility trial of BMS-275291 in patients with early stage breast cancer

artículo científico publicado en 2004

A rapid and sensitive method for determination of dimethyl benzoylphenyl urea in human plasma by using LC/MS/MS.

artículo científico publicado en 2003

A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer

artículo científico publicado en 2011

Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104

artículo científico publicado en 2010

Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial

artículo científico publicado en 2015

Adjuvant chemotherapy in older women with early-stage breast cancer

artículo científico publicado en 2009

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer ⬇️

artículo científico publicado en 2015

African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women

artículo científico publicado en 2009

American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting

artículo científico publicado en 2006

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

artículo científico publicado en 2010

American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

artículo científico publicado en 2010

Analysis of regional timelines to set up a global phase III clinical trial in breast cancer: the adjuvant lapatinib and/or trastuzumab treatment optimization experience

artículo científico publicado en 2013

Asking the right questions: investigating needs assessments and health-related quality-of-life questionnaires for use in oncology clinical practice

artículo científico publicado en 2007

Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update.

artículo científico publicado en 2012

CDK4 and CDK6 Inhibition in Breast Cancer - A New Standard

artículo científico publicado en 2016

CDK4/6 Inhibition in Early-Stage Breast Cancer: The New Standard?

scientific article published on 20 September 2020

Cancer susceptibility genes and their potential implication regarding systemic therapy for early-stage breast cancer

artículo científico publicado en 2015

Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer.

artículo científico publicado en 2015

Changes in breast density and circulating estrogens in postmenopausal women receiving adjuvant anastrozole.

artículo científico publicado en 2011

Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial).

artículo científico publicado en 2015

Clinical Notice for American Society of Clinical Oncology-College of American Pathologists guideline recommendations on ER/PgR and HER2 testing in breast cancer

scientific article published on 18 April 2011

Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis.

artículo científico publicado en 2010

Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study

artículo científico publicado en 2016

Comorbid condition care quality in cancer survivors: role of primary care and specialty providers and care coordination

artículo científico publicado en 2015

Comparative pharmacokinetics of weekly and every-three-weeks docetaxel.

artículo científico publicado en 2004

Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study

artículo científico publicado en 2009

Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer

artículo científico publicado en 2011

Comparison of breast cancer risk in women with and without systemic lupus erythematosus in a Medicare population.

artículo científico publicado en 2015

Comparison of changes in the lipid profile of postmenopausal women with early stage breast cancer treated with exemestane or letrozole.

artículo científico publicado en 2011

Complete radiologic response and long-term survival with use of systemic high-dose methotrexate for breast cancer-associated leptomeningeal disease.

scientific article published on 24 September 2012

Concordance of cancer patients' function, symptoms, and supportive care needs

artículo científico publicado en 2009

Coordination of care in breast cancer survivors: an overview.

artículo científico publicado en 2011

DNA Methylation Markers for Breast Cancer Detection in the Developing World

scientific article published on 12 July 2019

DNA methylation markers predict recurrence-free interval in triple-negative breast cancer

artículo científico publicado en 2020

Detection of cancer DNA in plasma of patients with early-stage breast cancer.

artículo científico publicado en 2014

Detection of circulating tumor cells in the cerebrospinal fluid: a new frontier.

artículo científico publicado en 2012

Development of a biomimetic peptide derived from collagen IV with anti-angiogenic activity in breast cancer ⬇️

artículo científico publicado el 1 de noviembre de 2011

Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis.

artículo científico publicado en 2010

Do breast cancer cell lines provide a relevant model of the patient tumor methylome?

artículo científico publicado en 2014

Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancer ⬇️

artículo científico publicado el 25 de febrero de 2011

Does a Picture Make a Difference? Ultrasound Guidance in the Management of the Axilla After Neoadjuvant Chemotherapy

artículo científico publicado en 2015

Does pre-existing diabetes affect prostate cancer prognosis? A systematic review.

artículo científico publicado en 2009

Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907.

artículo científico publicado en 2016

Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive 23Na MRI

artículo científico publicado en 2007

Enhancing therapeutic decision making when options abound: toxicities matter

artículo científico publicado en 2014

Estrogen receptor: a never ending story?

artículo científico publicado en 2011

Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese

artículo científico publicado en 2007

Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy

scientific article published on 25 October 2019

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

artículo científico publicado en 2016

Factors affecting pharmacokinetic variability following doxorubicin and docetaxel-based therapy.

artículo científico publicado en 2004

Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer

artículo científico publicado en 2009

Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer

artículo científico publicado en 2018

Genome-wide Methylation Analysis Identifies Genes Specific to Breast Cancer Hormone Receptor Status and Risk of Recurrence ⬇️

artículo científico publicado el 8 de agosto de 2011

Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial.

artículo científico publicado en 2017

Implementing a breast cancer registry and treatment plan/summary program in clinical practice: a pilot program

artículo científico publicado en 2012

Improving an electronic system for measuring PROs in routine oncology practice

artículo científico publicado en 2015

In vitro and in vivo clinical pharmacology of dimethyl benzoylphenylurea, a novel oral tubulin-interactive agent

artículo científico publicado en 2005

Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer.

artículo científico publicado en 2016

Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623.

artículo científico publicado en 2007

It's who you know: patient-sharing, quality, and costs of cancer survivorship care

artículo científico publicado en 2014

Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial

artículo científico publicado en 2016

Long term side effects of adjuvant chemotherapy in patients with early breast cancer

artículo científico publicado en 2015

Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer

artículo científico publicado en 2015

Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis

artículo científico publicado en 2008

Luteinizing hormone-releasing hormone agonists in premenopausal hormone receptor-positive breast cancer.

artículo científico publicado en 2007

Molecular determinants of post-mastectomy breast cancer recurrence

artículo científico publicado en 2018

Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study

artículo científico publicado en 2016

Monitoring of neoadjuvant chemotherapy using multiparametric, ²³Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer

artículo científico publicado en 2011

Multiparametric and Multimodality Functional Radiological Imaging for Breast Cancer Diagnosis and Early Treatment Response Assessment

artículo científico publicado en 2015

Multiparametric magnetic resonance imaging, spectroscopy and multinuclear (²³Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancer

artículo científico publicado en 2010

Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy with pegfilgrastim support

artículo científico publicado en 2006

Needs assessments can identify scores on HRQOL questionnaires that represent problems for patients: an illustration with the Supportive Care Needs Survey and the QLQ-C30.

artículo científico publicado en 2010

Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancer

artículo científico publicado en 2012

Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer.

artículo científico publicado en 2014

Older Adults' Views and Communication Preferences About Cancer Screening Cessation

artículo científico

Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer

artículo científico publicado en 2016

Past, present, and future challenges in breast cancer treatment

artículo científico publicado en 2014

Pathologic complete response in breast cancer patients receiving anthracycline- and taxane-based neoadjuvant chemotherapy: evaluating the effect of race/ethnicity

artículo científico publicado en 2010

Pathologic complete response to preoperative sequential doxorubicin/cyclophosphamide and single-agent taxane with or without trastuzumab in stage II/III HER2-positive breast cancer

artículo científico publicado en 2010

Patient-reported outcomes in the Translational Breast Cancer Research Consortium

scientific article published on 19 November 2019

Perceptions and needs of women with metastatic breast cancer: a focus on clinical trials

scientific article published on 25 March 2013

Pharmacogenetic pathway analysis of docetaxel elimination.

artículo científico publicado en 2008

Phase I study of continuous weekly dosing of dimethylamino benzoylphenylurea (BPU) in patients with solid tumours.

artículo científico publicado en 2006

Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomogr

artículo científico publicado en 2015

Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane

artículo científico publicado en 2008

Phase II trial of pegylated liposomal doxorubicin plus docetaxel with and without trastuzumab in metastatic breast cancer: Eastern Cooperative Oncology Group trial E3198.

artículo científico publicado en 2010

Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis.

artículo científico publicado en 2010

Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002.

artículo científico publicado en 2009

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.

artículo científico publicado en 2014

Quality of end-of-life care for patients with advanced cancer in an academic medical center

artículo científico publicado en 2011

Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial

artículo científico publicado en 2019

Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer.

artículo científico publicado en 2012

Re: predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteria.

artículo científico publicado en 2012

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update

artículo científico publicado en 2013

Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.

artículo científico publicado en 2017

Relationship Between Quality of Comorbid Condition Care and Costs for Cancer Survivors

artículo científico publicado en 2016

Reply to E.A. Rakha et al.

artículo científico publicado en 2015

Reply to G. Sauter et al

artículo científico publicado en 2009

Reply to L. Del Mastro and A. Prat

artículo científico publicado en 2017

Reply to R. Bhargava et al and K. Lambein et al.

artículo científico publicado en 2014

Research issues affecting preoperative systemic therapy for operable breast cancer.

artículo científico publicado en 2008

Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience

artículo científico publicado en 2014

Selection of Optimal Adjuvant Chemotherapy Regimens for Early Breast Cancer and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Gu

artículo científico publicado en 2016

Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) -Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Ca

artículo científico publicado en 2016

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update

artículo científico publicado en 2020

Sharing in care: engaging care partners in the care and communication of breast cancer patients

scientific article published on 04 June 2019

Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019

artículo científico publicado en 2015

Social support and its implications in older, early-stage breast cancer patients in CALGB 49907 (Alliance A171301)

artículo científico publicado en 2015

Still Refining Adjuvant Endocrine Therapy in Premenopausal Women: Not Too Much, Not Too Little

artículo científico publicado en 2016

Still waiting after 110 years: the optimal use of ovarian ablation as adjuvant therapy for breast cancer

artículo científico publicado en 2006

Symptoms, supportive care needs, and function in cancer patients: how are they related?

artículo científico publicado en 2008

Systemic therapy

artículo científico publicado en 2000

Systemic therapy

artículo científico publicado en 2001

Systemic therapy

artículo científico publicado en 2002

Systemic therapy.

artículo científico publicado en 1999

TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer

artículo científico publicado en 2014

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases.

artículo científico publicado en 2014

TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer.

artículo científico publicado en 2015

TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR+ Metastatic Triple-Negative Breast Cancer

scientific article published on 10 December 2019

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

artículo científico publicado en 2020

TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast Cancer

scientific article published on 29 October 2019

The Effects of a Remote-Based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial

scientific article published on 18 February 2020

The androgen receptor in breast cancer: learning from the past

artículo científico publicado en 2010

The impact of sharing results of a randomized breast cancer clinical trial with study participants

artículo científico publicado en 2008

Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations

artículo científico publicado en 2019

Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions

artículo científico publicado en 2019

Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases

artículo científico publicado en 2016

Treatment of HER2-positive breast cancer.

artículo científico publicado en 2013

Troponins for predicting cardiotoxicity from cancer therapy

scientific article published on 01 December 2000

Tumor targeting by conjugation of DHA to paclitaxel

artículo científico publicado en 2001

Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate dimethyl benzoylphenylurea (BPU) and its five metabolites in human plasma and urine for clinical pharmacology studies.

artículo científico publicado en 2005

Weekly paclitaxel in the adjuvant treatment of breast cancer.

artículo científico publicado en 2008

With maturity comes confidence: EBCTCG tamoxifen update

artículo científico publicado en 2011

Lista de obras de Antonio C. Wolff

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline

A PIK3CA mutation detected in plasma from a patient with synchronous primary breast and lung cancers.

A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB)

A Validated Model for Identifying Patients Unlikely to Benefit From the 21-Gene Recurrence Score Assay.

A method for determination of dimethyl benzoylphenyl urea (BPU) in human plasma by using LC/UV.

A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin

A randomized phase II feasibility trial of BMS-275291 in patients with early stage breast cancer

A rapid and sensitive method for determination of dimethyl benzoylphenyl urea in human plasma by using LC/MS/MS.

A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer

Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104

Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial

Adjuvant chemotherapy in older women with early-stage breast cancer

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer ⬇️

African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women

American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

Analysis of regional timelines to set up a global phase III clinical trial in breast cancer: the adjuvant lapatinib and/or trastuzumab treatment optimization experience

Asking the right questions: investigating needs assessments and health-related quality-of-life questionnaires for use in oncology clinical practice

Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update.

CDK4 and CDK6 Inhibition in Breast Cancer - A New Standard

CDK4/6 Inhibition in Early-Stage Breast Cancer: The New Standard?

Cancer susceptibility genes and their potential implication regarding systemic therapy for early-stage breast cancer

Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer.

Changes in breast density and circulating estrogens in postmenopausal women receiving adjuvant anastrozole.

Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial).

Clinical Notice for American Society of Clinical Oncology-College of American Pathologists guideline recommendations on ER/PgR and HER2 testing in breast cancer

Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis.

Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study

Comorbid condition care quality in cancer survivors: role of primary care and specialty providers and care coordination

Comparative pharmacokinetics of weekly and every-three-weeks docetaxel.

Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study

Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer

Comparison of breast cancer risk in women with and without systemic lupus erythematosus in a Medicare population.

Comparison of changes in the lipid profile of postmenopausal women with early stage breast cancer treated with exemestane or letrozole.

Complete radiologic response and long-term survival with use of systemic high-dose methotrexate for breast cancer-associated leptomeningeal disease.

Concordance of cancer patients' function, symptoms, and supportive care needs

Coordination of care in breast cancer survivors: an overview.

DNA Methylation Markers for Breast Cancer Detection in the Developing World

DNA methylation markers predict recurrence-free interval in triple-negative breast cancer

Detection of cancer DNA in plasma of patients with early-stage breast cancer.

Detection of circulating tumor cells in the cerebrospinal fluid: a new frontier.

Development of a biomimetic peptide derived from collagen IV with anti-angiogenic activity in breast cancer ⬇️

Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis.

Do breast cancer cell lines provide a relevant model of the patient tumor methylome?

Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancer ⬇️

Does a Picture Make a Difference? Ultrasound Guidance in the Management of the Axilla After Neoadjuvant Chemotherapy

Does pre-existing diabetes affect prostate cancer prognosis? A systematic review.

Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907.

Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive 23Na MRI

Enhancing therapeutic decision making when options abound: toxicities matter

Estrogen receptor: a never ending story?

Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese

Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

Factors affecting pharmacokinetic variability following doxorubicin and docetaxel-based therapy.

Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer

Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer

Genome-wide Methylation Analysis Identifies Genes Specific to Breast Cancer Hormone Receptor Status and Risk of Recurrence ⬇️

Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial.

Implementing a breast cancer registry and treatment plan/summary program in clinical practice: a pilot program

Improving an electronic system for measuring PROs in routine oncology practice

In vitro and in vivo clinical pharmacology of dimethyl benzoylphenylurea, a novel oral tubulin-interactive agent

Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer.

Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623.

It's who you know: patient-sharing, quality, and costs of cancer survivorship care

Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial

Long term side effects of adjuvant chemotherapy in patients with early breast cancer

Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer

Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis

Luteinizing hormone-releasing hormone agonists in premenopausal hormone receptor-positive breast cancer.

Molecular determinants of post-mastectomy breast cancer recurrence

Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study

Monitoring of neoadjuvant chemotherapy using multiparametric, ²³Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer

Multiparametric and Multimodality Functional Radiological Imaging for Breast Cancer Diagnosis and Early Treatment Response Assessment

Multiparametric magnetic resonance imaging, spectroscopy and multinuclear (²³Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancer

Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy with pegfilgrastim support

Needs assessments can identify scores on HRQOL questionnaires that represent problems for patients: an illustration with the Supportive Care Needs Survey and the QLQ-C30.

Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancer